They sure did, and that's exactly the point. Thacker Pass is projected to require CAPEX of US$2.93 billion. Financing has been secured from various channels, comprising: US$650 million from GM in exchange for exclusive offtake rights for the initial 15 years, a US$2.26 billion loan from the US Department of Energy (as previously mentioned by you), and the cap raise this week (US$275m), totalling US$3.185 billion. So even with US$2.91b of external funding already sorted (which is over 95% of projected CAPEX), LAC still had to dilute their existing shareholders by 25%, and at a 25% discount to boot.
Now, returning to my original (but connected) point. It's highly improbable for a strategic partner to invest funds equivalent to 2-3 times the market cap of a company, which is the likely requirement for AGY. The US Government isn't inclined to extend such a loan to AGY; the loan for Thacker Pass was earmarked for a strategic asset. Similarly, the Argentinian Government isn't poised to provide funding (because they're broke), nor is the Australian government solely because AGY is an Australian company. That really only leaves a pre-paid offtake, which has never occurred at the scale required by AGY (240% of market cap), handing over part ownership to someone else (which is just shareholder dilution in disguise) or non-government debt (which again is unlikely to cover 240% of market cap).
The most viable option entails leveraging a blend of financing sources, akin to what LAC did, including a cap raise. In the case of AGY I'm anticipating substantial dilution and a significant discount due to the current state of the lithium market.
- Forums
- ASX - By Stock
- AGY
- Ann: Rincon Lithium Project - Progress Update
AGY
argosy minerals limited
Add to My Watchlist
0.00%
!
1.5¢

Ann: Rincon Lithium Project - Progress Update, page-103
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.83M |
Open | High | Low | Value | Volume |
1.5¢ | 1.5¢ | 1.4¢ | $56.10K | 3.828M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
33 | 5774988 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 1305563 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
33 | 5774988 | 0.014 |
10 | 4229184 | 0.013 |
12 | 3774411 | 0.012 |
6 | 2201000 | 0.011 |
9 | 3649701 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 1305563 | 6 |
0.016 | 1454772 | 10 |
0.017 | 1631694 | 7 |
0.018 | 1383045 | 14 |
0.019 | 1921069 | 6 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online